Načítá se...
Pros and cons of transcatheter aortic valve implantation (TAVI)
Transcatheter aortic valve implantation (TAVI) or replacement (TAVR) was recently approved by the FDA for intermediate risk patients with severe aortic stenosis (AS). This technique was already worldwide adopted for inoperable and high-risk patients. Improved device technology, imaging analysis and...
Uloženo v:
| Vydáno v: | Ann Cardiothorac Surg |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AME Publishing Company
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5639221/ https://ncbi.nlm.nih.gov/pubmed/29062739 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/acs.2017.09.15 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|